Part 2: Legislation Testimony/Advocacy Statement Based on the health-related bill you selected, develop a 1- to 2-page Legislation Testimony/Advocacy Statement that addresses the following: · Advocate a position for the bill you selected and write testimony in support of your position. · Describe how you would address the opponent to your position. Be specific and provide examples. · Recommend at least one amendment to the bill in support of your position.

Expert Answer and Explanation
Legislation Testimony/Advocacy Statement
Part 1: Legislation Comparison Grid

Health-related Bill Name
H.R. 3 – The Lower Drug Costs Now Act

Bill Number
H.R. 3

Description
The Bill develops various requirements and programs relating to offering prices to prescription drugs. Also, the bill wants to give power to the US government to negotiate drug prices with private companies for Medicare recipient.

Federal or State?
This bill is meant to affect the federal government, and thus it is a federal bill.

Legislative Intent
The prices of prescription drugs are so high. According to a report by the speaker of the house, Nancy Pelosi, big pharmaceutical companies in the US have raised the prices of the drugs 10 times higher than how the drugs are sold outside the US (Pelosi, n. d).

Also, the report mentions that the firms make huge profits even though they sell the same drugs outside the US for lower prices. For instance, in the US, the cost of insulin drugs is ten times much higher than the cost of the same drugs in the UK, France, or Germany.

The cost of the drugs has increased drastically since 1990s (Sterling, 2018). The current laws forbid Medicare from negotiating drug prices. The intention of H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act is to grant Medicare power to negotiate the drug prices in a move to reduce the cost of drugs in the country.

Proponents/ Opponents
Proponents: The proponents of the bill are house democrats. All the democrats in the house unanimously voted for the bill. In addition, Jaime Herrera Beutler and Brian Fitzpatrick also jointed the democrats in supporting the bill. According to Zhou (2019), out of 422 representatives, 230 passed the bills.

Opponents: The bill was opposed by house republicans. However, two of the republicans supported the bill along with the democrats (Benen, 2019).

Apart from the house republicans, the White House led by president Donald Trump and the Senate Republicans have also opposed the bill.

Target Population
The bill targets people with chronic diseases such as diabetes. When the bill will become law, the prices of prescription drugs will reduce because the government will now have the power to negotiate of behalf of Medicare recipients.

Status of the bill (Is it in hearings or committees? Is it receiving press coverage?)
The bill has been discussed in the house of the representatives and passed. Currently, the bill is an act that will be submitted in the house of senate for further discussions and reviews. The American media has given the bill fair coverage because it affects their health.

After the bill was passed in the house of representatives, the speaker of the house gave a press conference about the bill and what she expects the senate to do about it.

General Notes/Comments

This bill will change the healthcare system by providing Medicare with power to develop tools that the institution can use to force drug companies to reduce the price of drugs.

As a result, the bill will ensure that people with chronic conditions get regular access to their prescriptions.

Part 2: Legislation Testimony/Advocacy Statement

My Position for the Bill

As a nurse I support the H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act bill due to the following reasons. First, the bill will make the work of nurses easy. Horvath and Anderson (2019) mention that a nurse has a responsibility of ensuring that his or her patient is given quality care. However, the current prices of prescription drugs prevent nurses from delivering on their mandates. The nurses find it hard to provide care because their patients do have access to prescription drugs due to the high prices.

Second, the bill will allow the reinvestment in researches and innovations for new treatments and cure. The savings that will be collected after reducing the prices of drugs will be used in supporting evidence-based innovations and researches to improve healthcare service delivery. The bill is in the favor of Americans. It will prevent the drug companies from raising the price of prescription drugs in the country will reducing the price in countries outside the us.

Persuading Opponents to Support a Bill

People in the house of representatives must on the same side for a bill to pass. Nurses are obligated to ethically lobby people opposing bills that can improve healthcare to support the laws. I will use my nursing communication skills to address the opponents to my position. First, I will talk to the opponents and highlight to them the importance of the bill to them and the people they represent.

Second, I will remind them of their manifesto of providing quality care for their constituents and tell them that this bill is one of the ways to fulfil the promise they made during campaigns. Third, I will take them for a walk-in medical facility so that they can see how people are suffering due to high prices of drugs. Lastly, I will ask them to think of their people before voting on the bill.

Using ACA to support the Bill

The affordable care act is another amendment that can be used to argue for the H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act bill. The ACA aims at improving the healthcare system in the US by ensuring that all Americans get medical covers. Also, the act aims at supporting researches and innovations which will increase the quality of healthcare in the Us. The H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act can be used to achieve some of the objects of ACA. For instance, when the government buys drugs at low costs from pharmaceutical companies, it will save the extra money for researches.

References

Benen, S. (2019). Despite GOP opposition, Dems pass bill to lower prescription costs. MSNBC. Retrieved from http://www.msnbc.com/rachel-maddow-show/despite-gop-opposition-dems-pass-bill-lower-prescription-costs

Horvath, J. C., & Anderson, G. F. (2019). The states as important laboratories for federal prescription drug cost-containment efforts. Jama, 321(16), 1561-1562.

Order A Similar Paper

Our Advantages

Quality Work
Unlimited Revisions
Affordable Pricing
24/7 Support
Fast Delivery

Order Now

Health-related Bill Name	H.R. 3 – The Lower Drug Costs Now Act
Bill Number	H.R. 3
Description	The Bill develops various requirements and programs relating to offering prices to prescription drugs. Also, the bill wants to give power to the US government to negotiate drug prices with private companies for Medicare recipient.
Federal or State?	This bill is meant to affect the federal government, and thus it is a federal bill.
Legislative Intent	The prices of prescription drugs are so high. According to a report by the speaker of the house, Nancy Pelosi, big pharmaceutical companies in the US have raised the prices of the drugs 10 times higher than how the drugs are sold outside the US (Pelosi, n. d). Also, the report mentions that the firms make huge profits even though they sell the same drugs outside the US for lower prices. For instance, in the US, the cost of insulin drugs is ten times much higher than the cost of the same drugs in the UK, France, or Germany. The cost of the drugs has increased drastically since 1990s (Sterling, 2018). The current laws forbid Medicare from negotiating drug prices. The intention of H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act is to grant Medicare power to negotiate the drug prices in a move to reduce the cost of drugs in the country.
Proponents/ Opponents	Proponents: The proponents of the bill are house democrats. All the democrats in the house unanimously voted for the bill. In addition, Jaime Herrera Beutler and Brian Fitzpatrick also jointed the democrats in supporting the bill. According to Zhou (2019), out of 422 representatives, 230 passed the bills.
Proponents/ Opponents	Opponents: The bill was opposed by house republicans. However, two of the republicans supported the bill along with the democrats (Benen, 2019). Apart from the house republicans, the White House led by president Donald Trump and the Senate Republicans have also opposed the bill.
Target Population	The bill targets people with chronic diseases such as diabetes. When the bill will become law, the prices of prescription drugs will reduce because the government will now have the power to negotiate of behalf of Medicare recipients.
Status of the bill (Is it in hearings or committees? Is it receiving press coverage?)	The bill has been discussed in the house of the representatives and passed. Currently, the bill is an act that will be submitted in the house of senate for further discussions and reviews. The American media has given the bill fair coverage because it affects their health. After the bill was passed in the house of representatives, the speaker of the house gave a press conference about the bill and what she expects the senate to do about it.
General Notes/Comments	This bill will change the healthcare system by providing Medicare with power to develop tools that the institution can use to force drug companies to reduce the price of drugs. As a result, the bill will ensure that people with chronic conditions get regular access to their prescriptions.